尿抗原检测肺炎链球菌对社区获得性肺炎临床价值研究

来源 :中国实用内科杂志 | 被引量 : 0次 | 上传用户:qiaozhang781209
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
据流行病学统计每年>14岁的社区获得性肺炎(CAP)患者约占居民总数的8.3‰,1/4的患者需要住院,病死率约为2.7%~([1])。成人CAP的主要致病菌仍为肺炎链球菌,由于该病原菌传统实验室诊断方法敏感度差,导致一部分CAP的初始治疗抗生素选择失败,不但延误了病情还增加了医疗资源的浪费和患者的经济负担~([2])。尿抗原检测肺炎链球菌是一种体外快速免疫层析(ICT)试验,为肺炎链球菌肺 According to the epidemiological statistics, community-acquired pneumonia (CAP) patients aged> 14 years each account for about 8.3% of the total number of residents, and one-fourth of patients require hospitalization with a mortality rate of about 2.7% ([1]). The main pathogens in adult CAP are still Streptococcus pneumoniae. Due to the poor sensitivity of the traditional laboratory diagnostic methods of this pathogen, the initial selection of antibiotics for CAP failed, which not only delayed the disease but also increased the waste of medical resources and the economy of the patients Burden ~ ([2]). Urinary Antigen Detection Streptococcus pneumoniae is an in vitro rapid immunochromatographic (ICT) assay for Streptococcus pneumoniae lung
其他文献
采用火箭电泳法、单向琼脂扩散法和放射免疫法,分别检测43例再障患者血液中AT-Ⅲ、α2-M、α1-AT及PC含量。结果表明,AT-Ⅲ、α2-M,PC抗原含量明显高于39例正常对照(P均<0.1),29例口服康力龙者AT-Ⅲ、α2-M,PC含量较14例未服康